The pharmaceutical cold chain logistics ushered in an outbreak period, and the market scale of 400 billion promoted industrial development.

In recent years, the consumption level of Chinese residents has been accelerated, the interconnection industry has developed in depth, and the pharmaceutical e-commerce industry has risen rapidly. However, under the influence of the epidemic, the market structure of pharmaceutical retail has quietly changed, and pharmaceutical e-commerce as a new entrance to pharmaceutical retail has run out of acceleration. According to the data of Ai Media, by 2022, the transaction scale of China's pharmaceutical e-commerce will reach 654.38+074 billion yuan, and the industry prospect is huge.

With the outbreak of the pharmaceutical e-commerce industry, the pharmaceutical cold chain logistics industry, as an important industrial chain, has also achieved rapid development. Lan Fu Finance Network has long been concerned about the development of the domestic pharmaceutical cold chain logistics industry. According to the research data of China IOT Medical Logistics Branch, by the end of 20 19, the storage area of medical logistics in China was 20,668,700 square meters, an increase of 17. 13% compared with 20 18, and the storage areas of normal temperature storage and cold storage accounted for 23.90% and 3.90% respectively.

In 20 19, there were 34,477 self-owned pharmaceutical logistics vehicles in China, including 8 146 refrigerated trucks, accounting for 23.62%, an increase of 6 1.96% compared with 20 18. In addition, in 20 19, the number of self-owned refrigerated trucks in China pharmaceutical cold chain enterprises reached 8 146, accounting for 2 1.4% of the total number of self-owned vehicles in the pharmaceutical industry in 20 19. Compared with 20 18, it increased by 6 1.0% year-on-year, and the domestic pharmaceutical cold chain logistics vehicle market grew rapidly.

On the whole, the infrastructure construction of domestic pharmaceutical cold chain logistics is gradually improving. The scale of pharmaceutical cold chain logistics market is also increasing year by year. According to the logistics data of China IOT Medicine, the total sales of pharmaceutical cold chain in China in 20 19 was about 339.503 billion yuan, an increase of 20.09% compared with 20 18. China IOT Pharmaceutical Logistics Branch predicts that the sales scale will reach 400 billion yuan by the end of 2020.

Under the background of such a huge market scale, many enterprises related to pharmaceutical cold chain logistics have also been born in China, including many leading A-share listed companies in the industry. Companies directly involved in pharmaceutical logistics business include Sinopharm Consistency, SF Holdings and Intel Group. Involved in the cold chain supporting equipment industry are Haier biology, ice wheel environment, snowman shares, iceberg cold and hot, etc.

Analysis of listed companies in pharmaceutical logistics industry

National drug consistency (000028):

The main business of Sinopharm Holdings includes drug distribution and drug retail. It is the only pharmaceutical retail integration platform of Sinopharm Group in China, and its business covers the whole industrial chain of "pharmaceutical distribution+pharmaceutical logistics+pharmaceutical retail+industrial investment".

At present, the company has built a "four-in-one" stepped logistics distribution network consisting of regional logistics centers, provincial logistics centers, urban distribution centers and distribution stations, expanding new modern logistics operation modes such as multi-warehouse operation, third-party logistics and cold chain management, and providing professional, efficient and fast drug distribution and logistics value-added services for customers and suppliers.

In the field of drug distribution, with the advantages of integration and scale, the company has formed a strong commercial network in the southern district of China. Up to now, the company has 47 subsidiaries in Guangzhou, Shenzhen, Foshan, Dongguan and other major regions such as Zhanjiang, Meizhou, Huizhou, Zhaoqing, Jiangmen, Shaoguan, Zhongshan, Nanning, Liuzhou, etc., among which 365 and 438+0 prefecture-level cities rank among the top three in the hospital direct sales market, achieving deep penetration in South China.

According to public information, as of June 30, 2020, the company has 975 secondary and tertiary medical institutions; 6,365,438+09 primary medical clients; There are 488 1 retail terminal customers. Moreover, the company has established 27 regional chain companies in 2/kloc-0 provinces, autonomous regions and municipalities directly under the central government, covering 75 cities at all levels in China, with more than 5,000 retail pharmacies, ranking first in the national pharmaceutical retail industry for six consecutive years.

SF Holdings (002352):

SF Holdings is a well-known enterprise in the domestic express delivery industry. In today's highly developed e-commerce, SF Express's daily express service can be described as a household name. In recent years, SF Express has also gone all out in medical cold chain logistics.

At present, relying on its advanced experience in logistics network, technical chassis and intensive resource management, the company constantly improves the deeper and wider medical service network, and provides customers with professional, safe and controllable one-stop medical logistics supply chain solutions and services, covering many fields such as pharmaceutical industry production, e-commerce, distribution and retail.

As of June 30, 2020, the company's medical network covers 237 prefecture-level cities and 2046 districts and counties, with 6 medical warehouses with a total area of 30,000 square meters and 46 medical transportation trunk lines running through the core cities of the country. During the reporting period, the company realized tax-free business income of 3,245,438+billion yuan, a year-on-year increase of 37.78%.

In the first half of 2020, SF Pharmaceuticals also gradually shifted from single drug transportation to diversification, guiding the continuous opening of the medical resource chain, and comprehensively deepening and upgrading cooperation with pharmaceutical production enterprises, circulation enterprises, vaccine production enterprises, disease control centers at all levels, hospitals, chain pharmacies and other enterprises in the pharmaceutical industry chain. During the epidemic, SF cooperated with leading domestic Internet hospitals and 1000 hospitals to provide patients with door-to-door distribution and comprehensive pharmacy services of normal temperature drugs and cold chain drugs.

Previously, SF Holdings once said that the company recognized the future development of the pharmaceutical cold chain industry, laid out the pharmaceutical cold chain in advance, set up a special team, and added more than 80 refrigerated trucks that met the GSP certification of drugs during the year, and planned to open seven pharmaceutical warehouses in Suzhou, Changsha, Changchun and Nanchang to meet the warehousing and distribution needs of pharmaceutical industry and pharmaceutical commercial customers.

Interest groups (0004 1 1):

As one of the regional leading enterprises in Zhejiang pharmaceutical circulation industry, Intel Group is mainly engaged in the wholesale and retail business of drugs and medical devices, that is, purchasing products from upstream pharmaceutical production or supply enterprises and then wholesaling them to downstream medical institutions, pharmacies and distributors. Or directly sold to consumers through retail terminals.

The subsidiaries of the company include Zhejiang Intel Logistics Co., Ltd., Jinhua Intel Pharmaceutical Logistics Co., Ltd. and Wenzhou Intel Pharmaceutical Logistics Co., Ltd., which mainly provide logistics services for the subsidiaries of Intel Group (Zhejiang Intel Pharmaceutical Co., Ltd. and regional subsidiaries of other counties and cities in the province). In addition to internal services, it also provides pharmaceutical logistics services to customers outside the Inter Group, which also involves the third-party pharmaceutical cold chain logistics business.

At present, the pharmaceutical cold chain logistics business is an important strategic support of Intel Group. Modern Logistics of Intel Group has more than 750 employees engaged in professional pharmaceutical logistics, with a storage area of over 200,000 cubic meters and more than 300 vehicles, including 50 refrigerated trucks, with an annual drug throughput of over 20 million pieces.

Zhejiang Intel Logistics Co., Ltd., a subsidiary, has 45 lines in Zhejiang Province by its own distribution. Cold chain distribution: all hospitals, pharmaceutical companies and pharmaceutical chains in the province are covered by refrigerated trucks, all customers in Hangzhou are covered by refrigerated trucks, and small and medium-sized customers choose verified refrigerated boxes for full coverage.

Jinhua Logistics Center, currently used by Zhejiang Inter Logistics Co., Ltd., a subsidiary, covers an area of 65,438+000 mu and was put into use at the end of 2065,438+06. At present, the business has covered the logistics distribution business in Wen Tai, northeast Jiangxi, northwest Fujian and southern Anhui in Jinli District, focusing on the development of third-party business to realize the warehousing of all products, and the logistics coverage network is expected to reach 20,000.

Ningbo Intel Logistics Co., Ltd., a subsidiary, currently has a warehouse area of more than 28,000 square meters, and has a cold storage of 1000 cubic meters in a cold storage. The reservoir area is equipped with advanced modern logistics facilities and equipment such as automatic sorting, electronic tag sorting and material transportation. The company mainly covers Jiaxing, Huzhou, Ningbo, Zhoushan and other neighboring provinces and cities such as Shanghai and Jiangsu.

Wenzhou Logistics Center, a subsidiary of Wenzhou Intel Pharmaceutical Logistics Co., Ltd., covers an area of 25 mu and has a storage area of 30,000 square meters. All-cooling design was put into use at the end of 20 16. A large-scale professional drug cold storage of 3,000 cubic meters will be built in the reservoir area. According to the storage requirements of cold chain drugs, it is divided into buffer area, waiting area, packaging material area, pallet storage area, shelf storage area and multi-temperature layer setting, which mainly undertakes the allocation, distribution and third-party logistics business in Wenzhou, Lishui, Taizhou (part) and Fujian Province, and the logistics coverage network is expected to reach 1 10,000.

Tesco (300937):

Tesco is a comprehensive service provider of pharmaceutical circulation focusing on "out-of-hospital market". Through innovative Internet and big data technology, efficient warehousing and logistics system, perfect category management and all-round and multi-level service system, the company gradually reduces the intermediate circulation links in the off-campus market, and provides convenient, efficient and low-cost drug circulation services for community medical terminals and primary medical institutions.

The company has a semi-automatic warehouse with a storage area of 26,000 square meters, equipped with WMS system and ERP system to realize information management. In 2065,438+08, the average number of shipments reached 50,000, effectively supporting the throughput of more than 2 billion sales.

In addition, the company built its own logistics system, equipped with 865,438+0 professional delivery vehicles, and opened 65,438+065,438+0 direct distribution trunk lines in various cities and prefectures of Sichuan Province, with more than 65,438+000 distribution trunk lines, covering most areas of Sichuan. Now the company's direct distribution logistics can be delivered in Chengdu the next day and in major cities in Sichuan in two days. At the same time, Yaoyigou has obtained the qualification of third-party drug logistics and distribution business, and is one of the few furniture enterprises in Sichuan Province with this qualification.

At present, Yaoyigou has established a complete drug variety system. The company has obtained the national or regional agency and distribution qualifications of more than 65,438 pharmaceutical companies with more than 7 100 pharmaceutical products, and has become the designated secondary distributor of more than 700 pharmaceutical companies with more than 4,000 varieties. In addition, it has established business cooperation relations with nearly 700 pharmaceutical commercial enterprises.

Jinyu Medicine (603882):

Jinyu Medicine's main business is to provide outsourcing and scientific research and technical services for more than 23,000 medical institutions across the country, including comprehensive tests such as physical and chemical mass spectrometry, genome test, pathological diagnosis, biochemical luminescence test and immunological test.

In terms of medical logistics, Guangzhou Jinyuda Logistics Co., Ltd. (hereinafter referred to as Jinyuda Logistics) under Jinyu Medical is an enterprise specializing in medical cold chain logistics. Since its establishment, it has always focused on the implementation and optimization of medical-related cold chains, providing safe, professional and efficient cold chain logistics services for customers in life sciences, medical inspection, health inspection, biomedicine and other fields.

In terms of logistics business, Jinyuda Logistics involves life science logistics, biological sample logistics, clinical trial logistics, biomedicine/diagnostic reagents, biological sample storage, biomedical materials logistics and so on. Taking life science logistics as an example, Jinyuda Logistics can provide normal temperature (25-30) logistics, cold storage (2-8) logistics, freezing (-15-25) logistics, dry ice (-20 -80) logistics, and meet the sample logistics services such as identification samples, genetic testing samples, cell samples and animal samples.

In terms of warehousing, Jinyuda Logistics has been focusing on the third-party warehousing and distribution integrated management business in the medical industry since its establishment, deeply cultivating the warehousing and distribution logistics industry chain, relying on national norms, taking chain data as the core, driven by refined management, and combining many years of warehousing and distribution management and service experience, it is committed to providing enterprises with efficient and low-cost warehousing and distribution hosting overall solutions.

At present, Jinyuda Logistics has 33 wholly-owned subsidiaries in major cities and economic regions in China, covering 3/kloc-0 provinces and cities and 2,334 county and township outlets. The company has more than 2,500 logistics specialists, and provides specimen/cargo transportation services to more than 2 1000 medical institutions and pharmaceutical companies nationwide every day, and undertakes to receive nearly 44 million tenders every year.

Huadong Medicine (000963):

Established in 1993, East China Pharmaceutical Co., Ltd. is a large-scale comprehensive pharmaceutical listed company integrating pharmaceutical research and development, manufacturing and sales, modern pharmaceutical logistics, health industry and manufacturing and sales of medical and beauty products. The company has four business segments: Chinese and western medicine, medical equipment, medicinal ginseng and health industry, covering pharmaceutical wholesale, pharmaceutical retail, third-party pharmaceutical logistics featuring cold chain, pharmaceutical e-commerce, hospital value-added services and characteristic big health industry.

Recently, East China Pharmaceutical Supply Chain Management (Hangzhou) Co., Ltd., a wholly-owned subsidiary of East China Pharmaceutical, received the first express business license for pharmaceutical cold chain enterprises in Zhejiang Province issued by Zhejiang Postal Administration. The company is a medical material reserve enterprise in Zhejiang and Hangzhou, with a complete cold chain logistics distribution service system and professional ability, and undertakes the supply and distribution tasks of medical reserve varieties in Hangzhou and the whole province.

In this regard, the company said that obtaining the first express business license for pharmaceutical cold chain enterprises in Zhejiang Province is a high recognition of the company's cold chain logistics distribution level and service ability by the market and regulatory authorities. In the future, East China Medicine will provide continuous power support for the healthy development of the cold chain logistics industry and better meet the cold chain consumption demand.

Analysis of listed companies of medical storage equipment technology

Haier Bio (688 139):

Haier Bio landed on the Science and Technology Innovation Board on October 25th, 20 19/KLOC-0, becoming the first enterprise in Qingdao to land on the Science and Technology Innovation Board. The company not only has the industry-leading core technology of low-temperature cold chain, but also can provide biomedical low-temperature products with full temperature range, full scene and full category. It has obvious advantages in product technical design, production technology and quality control, and is ahead of the international market.

In China, Haier Bio occupies more than 50% of the ultra-low temperature market, providing convenience for hospitals, blood stations, centers for disease control and research. Moreover, many national strategic projects, such as China Bone Marrow Bank, National Gene Bank and China Human Genetic Resource Bank, have adopted Haier's biological products. Overseas, under the guidance of Haier Group's strategy of "going out, going in and going up", Haier Bio has entered more than 0/00 countries and regions in the world.

At present, Haier Bio * * holds 288 patents and 34 US Energy Star certifications, and has led or participated in the drafting of 9 national and industry standards and 1 World Health Organization international standards. In the field of vaccination, Haier Bio-innovated the "Haile Miao" smart vaccine network, and people, machines and seedlings were interconnected to ensure that "people are good at seedlings", realize the whole process of accurate seedling selection, frozen seedlings and retrospective vaccination, and solve the "last mile" problem of vaccination.

Facing the different needs of prevention and control in COVID-19, Haier Bio-innovatively integrated the Internet of Things technology with biotechnology, and explored a set of public health full-scenario ecology, including biosafety products and scenario schemes such as safety sampling cabin, Internet of Things transfer box, mobile detection cabin and cloud eye smart laboratory.

Sifang Technology (603339):

Sifang technology has 6 wholly-owned subsidiaries, 1 research institute. Relying on the manufacturing of cold chain food deep processing equipment, the company has formed the industrial scale effect and gained remarkable industrial competitive advantages around the high-end intelligent equipment technology fields such as refrigeration, storage and transportation equipment, industrial heat exchange and energy-saving plates.

The company has the qualification of U, U2 and R steel seals of American Society of Mechanical Engineers, the qualification of design and manufacture of C2 movable pressure vessels in China, and the qualification of installation, renovation and maintenance of GC2 pressure pipes. Some refrigeration equipment products have passed the PED certification of EU pressure equipment and the CE certification of EU safety, and are sold to EU countries. In addition, the company's tank containers meet ISO, ASME, EN and GB standards, and have passed many product certifications such as Lloyd's Register of Shipping, Bureau VERITAS, Russian Register of Shipping and China Register of Shipping, and are qualified to provide products to the world.

The company is not only a supplier of quick-frozen equipment, but also provides customers with a series of services such as project consultation, solutions, equipment provision and technical support. The company has more than 3,000 high-quality customers at home and abroad, and its rich industry experience makes the company a professional cold chain solution provider.

At present, the company has 1 quick freezing equipment engineering technology research and development center and four laboratory testing platforms, which are suitable for all kinds of related testing. At the same time, the company participated in the formulation of a number of national standards and industry standards, and the Industry-University-Research cooperation mechanism was established and effectively operated, and established stable cooperative relations with many well-known universities such as Chinese Academy of Sciences, Nanjing University of Science and Technology, Shanghai Ocean University, Jiangnan University and China University of Mining and Technology.

As a leading manufacturer of cold chain equipment with comprehensive advantages in China, Sifang Technology has been widely recognized by the market and customers after nearly 40 years of development. Since the outbreak, many investors have paid attention to the application of Sifang technology's technology and products in the pharmaceutical cold chain. Sifang Technology also publicly stated that the cold storage built by the company can be used for vaccine storage, and the company is seeking vaccine cold chain storage related business.

Snowman shares (002639):

Snowman Co., Ltd. was established in March 2000. The company has two industrial parks, Binhai and Liren, with more than 10 entity subsidiaries and more than 1,000 employees. After more than ten years of development, the company has become a high-tech enterprise with compressor as its core industry, integrating the research and development, design, manufacture, sales, engineering installation and after-sales service of waste heat recovery power generation, new energy, industrial and commercial refrigeration and its complete refrigeration system.

In the ice-making equipment manufacturing industry, Yeti shares rank among the best in the comprehensive market share and is one of the large enterprises in the ice-making industry. It is the unit where the ice-making working group of the National Cold Standardization Committee is located, and is responsible for formulating national and market standards. The company has two internationally renowned compressor brands, SRM and RefComp, with rich product series and leading technology.

In the field of cold chain logistics, Yeti Co., Ltd. has been committed to improving the overall level of cold chain ecology in China for a long time, and can provide product series matching according to different refrigeration needs, ranging from 10 cubic meter to 200,000 tons of cold storage, with rich product lines, meeting the requirements of the whole cold chain for fruits, vegetables, aquatic products, frozen dairy products, medicines and vaccines and other cold and fresh products from origin to retail storage to the last mile distribution.

The company has some characteristic cold chain products to fill the technical gap in the domestic cold chain logistics field, such as large ammonia+carbon dioxide refrigeration unit, mobile refrigeration equipment, refrigeration integrated machine and so on. RefComp refrigeration machine can ensure that cold chain drugs can be kept at low temperature and constant temperature during transportation.

At present, Yeti's Refcomp refrigeration integrated machine is not only used in the provincial vaccine warehouse project of Hebei CDC, but also used in the refrigeration projects of medical articles in Jinan, Zhengzhou, Wuxi, Siping, Zhangjiakou and other CDC. Previously, Yeti shares publicly stated that the RefComp all-in-one machine developed by the company can be applied to refrigeration equipment in the field of pharmaceutical cold chain logistics, especially for drugs with temperature requirements such as refrigeration and freezing in drug storage and transportation, which can ensure that cold chain drugs are kept at low temperature and constant temperature during transportation.

Songzhi shares (002454):

Zhizhi Co., Ltd. is mainly engaged in the research and development, production and sales of thermal management related products in the fields of automobile, rail transit and cold chain logistics, and is a leading enterprise in domestic automobile thermal management related products. Products are widely used in large and medium-sized buses, buses, special vehicles, trucks, light buses, rail cars and refrigerated trucks.

The company has become the leader of automobile thermal management products with the richest product variety, the strongest technical development capability and the leading market share among the independent brand thermal management related product suppliers in China. At present, the company has incorporated the core components related to automobile air conditioning, automobile air conditioning system, battery thermal management related components and systems, ATS engine cooling system and other products into the field of vehicle thermal management system.

Recently, the company announced the acquisition of 55% equity of Jingbin Ocean Heating and Cooling Industry (Dalian) Co., Ltd. has been delivered. In the share purchase agreement signed between our company and Jingbin Thermal Technology Co., Ltd. (hereinafter referred to as "KTT"), KTT has fulfilled all delivery conditions.

Jingbin Dayang Heating and Cooling Industry (Dalian) Co., Ltd. is an enterprise specializing in the production, sales and service of R&D, automobile air-conditioning condensers and evaporators. As the base of Japanese Keihin Group specializing in the production of automobile air-conditioning condensers and evaporators in China, it mainly supplies automobile air-conditioning related parts for joint venture brand automobile enterprises such as Guangqi Honda, Dongfeng Honda, SAIC Volkswagen, FAW-Volkswagen and Changan Ford.

As for the medical cold chain logistics related business, Songzhi shares also publicly stated that the cold chain logistics unit of the company's cold chain logistics unit business has entered the field of medical logistics and transportation, and has carried products including medical drugs and vaccines. At present, the company's cold chain logistics unit products can be widely used in the transportation of fresh food, food, medicines, vaccines and other fields.

Ice wheel environment (0008 1 1):

Ice wheel environment was established in 1956, which is a diversified and international comprehensive equipment industrial enterprise. The company's main business covers low-temperature refrigeration, central air conditioning, environmental protection heating, energy and chemical equipment, precision casting, intelligent service, hydrogen energy development and other industrial clusters.

At present, the company has set up production bases, scientific research centers and marketing service agencies in more than 40 countries around the world, and provides service guarantee for users in more than 20 countries and regions with safe, environmentally friendly and energy-saving housekeeping solutions and intelligent system integration capabilities.

The company also has five national-level scientific and technological innovation platforms, such as enterprise technology center recognized by the state, and four provincial-level scientific and technological innovation platforms, such as Shandong Key Laboratory of Energy Saving and Environmental Protection Refrigeration Equipment. It has been recognized as a key high-tech enterprise of the National Torch Program, with 263 national patented technologies, and presided over and participated in the formulation of 20 national standards and 32 industry standards.

As an enterprise dedicated to providing customers with professional system solutions in the field of temperature control, Ice Wheel Environment publicly stated that the company's refrigeration equipment has been used in the pharmaceutical industry for a long time. In recent years, there are customers such as Haizheng Pharmaceutical, Luye Pharmaceutical, Qilu Pharmaceutical and Jiuzhoutong. In extreme cases, some medical supplies (such as novel coronavirus mRNA vaccine) need an environment of -70 to be preserved for a long time. At present, a business department of the company is building the a -70 ultra-low temperature biological cold storage of a company under Fosun Pharma.

Icebergs are hot and cold (000530):

The predecessor of Iceberg Cold and Hot is Dalian Refrigerator Factory, which was founded in 1930. It is the core enterprise of Dalian Iceberg Group Co., Ltd., a leading enterprise in China industrial refrigeration industry. With cold and hot technology as the core, the company has built a complete cold and hot industrial chain and built a cold and hot industrial base supported by Dalian, Wuhan and Changzhou.

Relying on Dalian Hot and Cold Science and Technology Innovation Center and Intelligent Manufacturing Demonstration Base, the company innovates business models and develops new formats. With the development of customers' needs, it accelerates the pace of transformation and upgrading around the smile curve. Relying on the complete hot and cold industrial chain, it actively upgrades to the hot and cold value chain with scientific and technological innovation, intelligent manufacturing and hot and cold services, constantly expanding the open and inclusive hot and cold ecosystem and constantly leading the development of China's hot and cold industry.

As the largest manufacturer of industrial refrigeration equipment in China, Iceberg Cold and Hot has previously publicly stated that the company and related affiliated companies have undertaken medical cold storage projects in recent years, and related solutions can be applied to vaccine storage.